Trial Profile
Efficacy and Safety of Bevacizumab as Neoadjuvant Treatment in Patients With Locally Advanced Inflammatory Breast Cancer, a Pilot Study.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Cyclophosphamide; Docetaxel; Epirubicin; Fluorouracil; Trastuzumab
- Indications Inflammatory breast cancer
- Focus Therapeutic Use
- 14 Dec 2013 Results presented at the 36th Annual San Antonio Breast Cancer Symposium.
- 25 Jun 2013 New trial record